Enrico Morello
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Enrico Morello has a total of 129 co-authors. Here are the top co-authors by number of shared publications:
- Michele Malagola
Unit of Blood Diseases and Bone Marrow Transplantation, Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy
11 shared publications - Mirko Farina
Unit of Blood Diseases and Bone Marrow Transplantation, Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy
10 shared publications - Simona Bernardi
Unit of Blood Diseases and Bone Marrow Transplantation, Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy
10 shared publications - Nicola Polverelli
Unit of Bone Marrow Transplantation and Cellular Therapies, Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
7 shared publications Domenico Russo
Unit of Blood Diseases and Bone Marrow Transplantation, Cell Therapies and Hematology Research Program, Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy
6 shared publications- Domenico Russo
Department of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy
6 shared publications
Latest Publications
- Open Access
- 14 November 2026
- Published by Wiley in Cancer Medicine
- Vol. 15 (11)
Psychosocial Well‐Being in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Their Caregivers: A Prospective Study
Although allogeneic hematopoietic stem cell transplantation (allo‐HSCT) offers curative potential for several hematologic malignancies, it is associated with a substantial psychological burden. However, prospective studies simultaneously evaluating psychological distress, quality of life, unmet needs, caregiver strain, and baseline psychosocial vulnerability remain limited. We therefore conducted a prospective single‐center observational study of 115 adult allo‐HSCT recipients assessed peri‐transplant (T0), and at 6 (T1) and 12 (T2) months. Thirty‐two caregivers provided at least one Family Strain Questionnaire—Short Form response, and 31 completed all items required for score calculation. The Psychosocial Assessment of Candidates for Transplantation (PACT) was available for 80 patients and was analyzed exploratorily because the Italian version has not undergone formal psychometric validation. Scores were generally favorable (median score: 38), with only nine patients classified as having low psychosocial suitability (PACT score ≤ 29). Clinically relevant distress (Distress Thermometer ≥ 4) was observed in 67.5%, 69.7%, and 47.4% of patients with valid data at T0, T1, and T2, respectively. Psychological Distress Inventory scores were higher at 6 months than at T0; the 12‐month estimate was numerically lower than at 6 months, but neither the T1–T2 nor the T0–T2 contrast was statistically significant. Informational and communication needs remained frequent, while several SF‐36 domains worsened at 6 months and improved at 12 months. Mean caregiver strain score did not change significantly over time; however, more than half of assessed caregivers were classified in areas indicating that psychological support was strongly recommended or urgent at each time point. These findings indicate distinct psychosocial trajectories among participants and support the potential value of repeated multidimensional psychosocial assessment during the first year after allo‐HSCT.
- 14 November 2026
- Published by Wiley in Cancer Medicine
- Vol. 15 (11)
Open AccessPsychosocial Well‐Being in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Their Caregivers: A Prospective Study
Although allogeneic hematopoietic stem cell transplantation (allo‐HSCT) offers curative potential for several hematologic malignancies, it is associated with a substantial psychological burden. However, prospective studies simultaneously evaluating psychological distress, quality of life, unmet needs, caregiver strain, and baseline psychosocial vulnerability remain limited. We therefore conducted a prospective single‐center observational study of 115 adult allo‐HSCT recipients assessed peri‐transplant (T0), and at 6 (T1) and 12 (T2) months. Thirty‐two caregivers provided at least one Family Strain Questionnaire—Short Form response, and 31 completed all items required for score calculation. The Psychosocial Assessment of Candidates for Transplantation (PACT) was available for 80 patients and was analyzed exploratorily because the Italian version has not undergone formal psychometric validation. Scores were generally favorable (median score: 38), with only nine patients classified as having low psychosocial suitability (PACT score ≤ 29). Clinically relevant distress (Distress Thermometer ≥ 4) was observed in 67.5%, 69.7%, and 47.4% of patients with valid data at T0, T1, and T2, respectively. Psychological Distress Inventory scores were higher at 6 months than at T0; the 12‐month estimate was numerically lower than at 6 months, but neither the T1–T2 nor the T0–T2 contrast was statistically significant. Informational and communication needs remained frequent, while several SF‐36 domains worsened at 6 months and improved at 12 months. Mean caregiver strain score did not change significantly over time; however, more than half of assessed caregivers were classified in areas indicating that psychological support was strongly recommended or urgent at each time point. These findings indicate distinct psychosocial trajectories among participants and support the potential value of repeated multidimensional psychosocial assessment during the first year after allo‐HSCT.
- Open Access
- 7 August 2026
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 32 (11) , 1473-1488
The Role of Physical Therapy Across the Transplant Trajectory in Allogeneic Hematopoietic Stem Cell Transplantation, A Systematic Review and Clinical Framework
- 7 August 2026
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 32 (11) , 1473-1488
Open AccessThe Role of Physical Therapy Across the Transplant Trajectory in Allogeneic Hematopoietic Stem Cell Transplantation, A Systematic Review and Clinical Framework
- Open Access
Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50
Background: The Comprehensive Geriatric Assessment (CGA) has proven to be a valuable tool for providing a more comprehensive health evaluation of allogeneic stem cell transplantation (allo-SCT) recipients. Methods: We prospectively developed and tested a new Simplified Geriatric Score-4 (SGS-4) on 135 consecutive patients aged ≥50 years who underwent allo-SCT between 2020 and 2023. Each CGA component was individually analyzed for its association with overall survival (OS), non-relapse mortality (NRM), and cumulative incidence of relapse (CIR). Then, we performed a two-factor analysis (FA) using oblimin rotation and Bartlett estimation on all CGA components and sex. Based on component weights, a simplified geriatric score-4 score (SGS-4) was created: [Gait Speed] + 2 × [Hand Grip] + Geriatric 8 + 1.5 × [Sex]. ROC analysis defined three fitness groups, frail (≤13), prefrail (>13–22.5), and fit (>22.5). Results: Reduced hand grip strength and impaired mini mental state examination (MMSE) were associated with worse OS and higher NRM. Vulnerable Elders Survey (VES-13) and Fondazione Italiana Linfomi (FIL) scores also indicated poorer OS, though with uneven group sizes. Other CGA domains and the Hematopoietic Cell Transplantation–Comorbidity Index (HCT-CI) showed no significant prognostic value. The SGS-4 effectively stratified patients into three fitness groups, with those in the frail category experiencing lower OS and an increased risk of relapse. Conclusions: The new Simplified Geriatric Score-4 (SGS-4) based on three CGA domains (gait speed, hand grip, Geriatric 8) and sex effectively predicts OS and CIR risk in patients aged ≥50 years undergoing allo-SCT. The study’s small sample size and disease heterogeneity warrant further validation in larger cohorts.
Open AccessDevelopment of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50
Background: The Comprehensive Geriatric Assessment (CGA) has proven to be a valuable tool for providing a more comprehensive health evaluation of allogeneic stem cell transplantation (allo-SCT) recipients. Methods: We prospectively developed and tested a new Simplified Geriatric Score-4 (SGS-4) on 135 consecutive patients aged ≥50 years who underwent allo-SCT between 2020 and 2023. Each CGA component was individually analyzed for its association with overall survival (OS), non-relapse mortality (NRM), and cumulative incidence of relapse (CIR). Then, we performed a two-factor analysis (FA) using oblimin rotation and Bartlett estimation on all CGA components and sex. Based on component weights, a simplified geriatric score-4 score (SGS-4) was created: [Gait Speed] + 2 × [Hand Grip] + Geriatric 8 + 1.5 × [Sex]. ROC analysis defined three fitness groups, frail (≤13), prefrail (>13–22.5), and fit (>22.5). Results: Reduced hand grip strength and impaired mini mental state examination (MMSE) were associated with worse OS and higher NRM. Vulnerable Elders Survey (VES-13) and Fondazione Italiana Linfomi (FIL) scores also indicated poorer OS, though with uneven group sizes. Other CGA domains and the Hematopoietic Cell Transplantation–Comorbidity Index (HCT-CI) showed no significant prognostic value. The SGS-4 effectively stratified patients into three fitness groups, with those in the frail category experiencing lower OS and an increased risk of relapse. Conclusions: The new Simplified Geriatric Score-4 (SGS-4) based on three CGA domains (gait speed, hand grip, Geriatric 8) and sex effectively predicts OS and CIR risk in patients aged ≥50 years undergoing allo-SCT. The study’s small sample size and disease heterogeneity warrant further validation in larger cohorts.
- 2 July 2025
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 69, 54-62
Impact of transforming growth factor-β2 enriched food for special medical purposes on nutritional status, microbiota and clinical outcomes after allogeneic hematopoietic stem cell transplantation: prospective analysis of 192 consecutive patients
- 2 July 2025
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 69, 54-62
Impact of transforming growth factor-β2 enriched food for special medical purposes on nutritional status, microbiota and clinical outcomes after allogeneic hematopoietic stem cell transplantation: prospective analysis of 192 consecutive patients
- Open Access
- 4 April 2024
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 30 (6) , 580.e1-580.e14
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome
- 4 April 2024
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 30 (6) , 580.e1-580.e14
Open AccessEvaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome
- Open Access
- 8 March 2024
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 30 (5) , 548.e1-548.e4
Nutritional Strategies To Improve VRE Control
- 8 March 2024
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 30 (5) , 548.e1-548.e4
Open AccessNutritional Strategies To Improve VRE Control
- Open Access
- 29 November 2023
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 59 (2) , 293
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
- 29 November 2023
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 59 (2) , 293
Open AccessCorrection: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
- Open Access
- 4 November 2023
- Published by Elsevier in Transplant Immunology
- Vol. 81, 101954
Nutritional intervention with TGF-beta enriched food for special medical purposes (TGF-FSMP) is associated with a reduction of malnutrition, acute GVHD, pneumonia and may improve overall survival in patients undergoing allogeneic hematopoietic stem transplantation
- 4 November 2023
- Published by Elsevier in Transplant Immunology
- Vol. 81, 101954
Open AccessNutritional intervention with TGF-beta enriched food for special medical purposes (TGF-FSMP) is associated with a reduction of malnutrition, acute GVHD, pneumonia and may improve overall survival in patients undergoing allogeneic hematopoietic stem transplantation
- Open Access
- 19 October 2023
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 59 (1) , 138-140
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
- 19 October 2023
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 59 (1) , 138-140
Open AccessCMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation